Eleni Aklillu

Eleni Aklillu

Professor | Research team leader
Telephone: +46852483556
Visiting address: Widerströmska huset Tomtebodavägen 18 A, plan 3, 17165 Solna
Postal address: K9 Global folkhälsa, K9 GPH Aklillu, 171 77 Stockholm

About me

  • I am Professor of Global Health Pharmacology, Senior Research Scientist, and Leader of the Global Health Pharmacology and Therapeutics (GH-Pharma) Research Group at the Department of Global Public Health, Karolinska Institutet, Sweden. My research addresses major global health challenges affecting low- and middle-income countries, particularly in sub-Saharan Africa, with a focus on optimizing the prevention and treatment of infectious diseases. I investigate how genetic variation, drug-drug interactions, co-infections, comorbidities, nutrition, and environmental factors influence the safety, efficacy, and effectiveness of medicines, generating evidence that informs clinical practice, public health policy, and international treatment guidelines.

    Over the past three decades, I have led multidisciplinary clinical research and capacity-strengthening programmes across Ethiopia, Kenya, Tanzania, Uganda, and Rwanda, addressing HIV/AIDS, tuberculosis, malaria, neglected tropical diseases, antimicrobial resistance, and maternal and child health. By integrating clinical pharmacology, neuropsychopharmacology, clinical trials, pharmacogenomics, pharmacokinetics/pharmacodynamics (PK/PD),  drug-drug interaction studies, biomarker discovery, implementation science, pharmacovigilance, and regulatory science, my work has contributed to treatment optimization, evidence-based policy development, health systems strengthening, and the advancement of precision medicine.

    Through multinational programmes funded by EDCTP, the European Union, Sida, and the Swedish Research Council, I have contributed to strengthening clinical trial infrastructure, pharmacovigilance systems, medicines regulation, research ethics, and regulatory science across Africa while fostering sustainable South-South and North-South partnerships. My research has supported the translation of scientific discoveries into policies and practices that improve patient care and public health outcomes.

    A central component of my work is research capacity and institutional strengthening. I have supervised and mentored more than 30 PhD graduates, postdoctoral fellows, and early-career scientists, many of whom now hold leadership positions in universities, National Medicines Regulatory Authorities, WHO, Africa CDC, and public health programmes. To date, my research programmes have generated more than 190 peer-reviewed publications and contributed to building sustainable scientific leadership and research excellence across Africa.

    Education
    • Postdoctoral Training in Clinical Pharmacology, Karolinska Institutet, Sweden
    • PhD in Molecular Genetics, Karolinska Institutet, Sweden (2003)
    • MSc in Biochemistry, Addis Ababa University, Ethiopia (1996)
    • Bachelor of Pharmacy (B.Pharm), Addis Ababa University, Ethiopia (1987)
     
    Selected Honours and Leadership Roles
    • Member, WHO-TDR Global External Review Group (since 2022)
    • Member, WHO-TDR Scientific Working Group on Implementation Research (since 2021)
    • Donald Mackay Medal (2020), awarded by the Royal Society of Tropical Medicine and Hygiene and the American Society of Tropical Medicine and Hygiene for outstanding contributions to tropical health
    • Member, Committee for Development Research, Swedish Research Council (2016–2020)
    • Vice-Chair and Member, Strategic Advisory Committee, EDCTP (2014–2018)
    • Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) (2015)
    • Fellow of the African Academy of Sciences (FAAS) (2015)

    Funding

    European Commission (Framework Programmes and Horizon Europe), EDCTP1, EDCTP2, Global Health EDCTP3, the Swedish Research Council, the Swedish Research Council for Sustainable Development (Formas), Sida bilateral research cooperation programmes, the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies (TEI-MAV+), and International Vaccine Institute (IVI)I). As Principal Investigator or Coordinating Investigator, she has attracted more than SEK 300 million (approximately EUR 30 million) in externally funded research grants through competitive international and national funding schemes.

    Research Group Website:  GH-Pharma Research Group

Research

  • Research Areas: Global Health Pharmacology, Neuropsychopharmacology, Pharmacogenomics, Precision Medicine, Clinical Trials, HIV/AIDS, Tuberculosis, Malaria, Neglected Tropical Diseases, Antimicrobial Resistance, Maternal and Child Health, Pharmacovigilance, Regulatory Science, Implementation Science, and Health Systems Strengthening.

    Clinical Pharmacology and Precision Medicine

    • Pharmacogenomics of drug metabolism, efficacy, and toxicity
    • Precision medicine and individualized therapy 
    • Pharmacokinetics/pharmacodynamics (PK/PD)
    • Drug-drug interactions and treatment optimization
    • Biomarker discovery and translational medicine
    • Infectious disease pharmacology and therapeutics
    • Antimicrobial resistance and antimicrobial stewardship

    HIV/AIDS Research

    • Optimization of antiretroviral therapy (ART)
    • Pharmacokinetics and pharmacogenomics of ARVs
    • HIV-TB co-treatment and integrated care
    • Antiretroviral drug-drug interactions
    • HIV treatment during pregnancy and breastfeeding
    • Drug-induced toxicity, treatment safety, and long-term outcomes

    Tuberculosis Research

    • Optimization of TB-HIV co-treatment strategies
    • Timing of ART initiation during TB treatment
    • Pharmacokinetics and pharmacogenomics of anti-TB drugs
    • Biomarkers of treatment response and toxicity
    • Drug-resistant tuberculosis (MDR/RR-TB)
    • Host-directed therapies and precision treatment approaches

    Malaria Research

    • Optimization of antimalarial treatment and prevention
    • HIV-malaria drug interactions
    • Pharmacogenomics of antimalarial treatment response
    • Malaria prevention during pregnancy
    • Safety, effectiveness, and implementation of malaria control interventions

    Neglected Tropical Diseases (NTDs)

    • Schistosomiasis, including female genital schistosomiasis
    • Lymphatic filariasis and Onchocerciasis
    • Soil-transmitted helminth infections 
    • Optimization of preventive chemotherapy and mass drug administration
    • Safety monitoring and pharmacovigilance of NTD control and  interventions

    Maternal and Child Health

    • Treatment optimization during pregnancy and lactation
    • Maternal, fetal, and neonatal pharmacology
    • Prevention and management of infectious diseases in pregnancy
    • Medicine safety in mothers and children

    Pharmacovigilance and Medicine Safety

    • Post-marketing surveillance of medicines and vaccines
    • Adverse drug reaction detection and monitoring
    • Pharmacovigilance systems strengthening
    • Signal detection, risk assessment, and risk management
    • Active safety surveillance in resource-limited settings

    Medicines Regulation and Regulatory Science

    • Strengthening National Medicines Regulatory Authorities
    • Regulatory systems and policy development
    • Clinical trial oversight and regulatory review
    • Research ethics and Good Clinical Practice (GCP)
    • Regulatory science and evidence-based decision-making
    • Regulatory capacity strengthening and regional harmonization in Africa
    Research Capacity and Health Systems Strengthening
    • Clinical trial capacity development
    • Research leadership and mentorship
    • Implementation science and knowledge translation
    • Health systems strengthening
    • Pharmacovigilance and regulatory capacity development
    • Sustainable Africa-Europe scientific partnerships and institutional strengthening

Articles

All other publications

Grants

Employments

  • Professor, Tropical Pharmacology, Department of Global Public Health, Karolinska Institutet, 2023-
  • Professor, ME Infektion, Karolinska Universitetssjukhuset, 2023-
  • Professor, Tropical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, 2020-2023

Degrees and Education

  • Docent, Karolinska Institutet, 2009
  • Doctor Of Philosophy, Institute of Environmental Medicine, Karolinska Institutet, 2003

Leadership and responsibility assignments

  • Research team leader, Global Health Pharmacology and Therapeutics (GH-Pharma) – Eleni Aklillu's research group, Department of Global Public Health, Karolinska Institutet, 2023-

Supervision

News from KI

Events from KI